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Abstract
Background: Genomic characterization of rotavirus (RoV) has not been adopted at large-scale due to the
complexity of obtaining sequences for all 11 segments, particularly when feces are used as starting material.
Methods: To overcome these limitations, we developed a novel RoV capture and genome sequencing method
combining commercial enzyme immunoassay plates and a set of routinely used reagents.
Results: Our approach had a 100% success rate, producing >90% genome coverage for diverse RoV present in
fecal samples (Ct < 30).
Conclusions: This method provides a novel, reproducible and comparatively simple approach for genomic RoV
characterization and could be scaled-up for use in global RoV surveillance systems.
Trial registration (prospectively registered): Current Controlled Trials ISRCTN88101063. Date of registration:
14/06/2012
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Background
The control of diarrheal diseases remains a constant
public health challenge; current estimates predict that
diarrhea results in approximately 800,000 deaths and
90,000 disability adjusted life years (DALYs) globally per
year [1, 2]. The greatest burden of disease, and conse-
quently the biggest impact on DALYs, arises in children
under the five years of age residing in countries with a
low economic index [3]. Diarrhea is a complex syn-
drome that can be induced by a number of perturbations
of the gastrointestinal tract, but the disease is generally
associated with specific viruses, bacteria and parasites
that induce diarrhea via differing mechanisms. Despite
the availability of efficacious vaccines against rotavirus A
(RoV), this ubiquitous, highly virulent and extremely
transmissible virus remains the most common cause of
diarrhea in children under the age of two years globally
[4, 5]. RoV is the suspected etiological agent in 39% and
45% of all hospital admissions related to diarrhea glo-
bally and in Asia, respectively. In our setting in Vietnam,
where vaccine uptake has been limited, RoV is estimated
to be responsible for between 40 and 60% of all child-
hood diarrheal infections requiring hospitalization [6, 7].
RoV is a non-enveloped virus and a member of the
Reoviridae with a genome comprised of 11 segments
(g1-g11) of double-stranded RNA (dsRNA) of differing
lengths [8]. These 11 segments encode the six structural
(NSP1-NSP6) and six non-structural proteins (VP1-4,
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VP6 and VP7) that constitute a functional, infectious
virion. Currently, sequence variation within two of the
genes encoding the outer viral capsid proteins (VP7 and
VP4) permits a basic differentiation of RoV strains [9].
The sequences of the VP7 (glycoprotein) and the VP4
(protease-sensitive protein) genes define the G-type and
P-type, respectively. G1P[8] is consistently the most
frequent RoV A G/P type isolated from symptomatic
humans globally, but 27 other G types and 37 alternative
P types have been described [10, 11].
G/P typing has historically been considered to be ad-
equate for RoV surveillance, epidemiology and for the
identification of escapees during vaccine efficacy studies
[12–14]. However, sequencing of just 2/11 genome
segments disregards approximately 81% (15,138 bp/
18,550 bp considering the SA11 reference sequence [15])
of the genome that exists outside these capsid genes,
thus limiting our phylogenetic understanding of the
other genome segments and the evolutionary processes
that may be active across the RoV genome. To address
this limitation, a more complex RoV classification system
using all eleven genomic segments has been established,
resulting in a whole genome nomenclature of Gx-P[x]-Ix-Rx-
Cx-Mx-Ax-Nx-Tx-Ex-Hx, representing VP7-VP4-VP6-VP1-
VP2-VP3-NSP1-NSP2-NSP3-NSP4-NSP5, respectively [10].
Currently, the purification of pure RoV RNA suitable
for direct genome sequencing is largely dependent on
viral culture. This method is laborious, unreliable and
induces bias for sequencing of high yield, cultivable viral
particles. For RoV genotyping, RoV RNA is extracted
directly from fecal samples and PCR amplification is
performed on the VP4 and VP7 regions. This method is
fundamentally unsuitable for genome sequencing via
next generation sequencing owing to the high amount of
contaminating (non-viral) nucleic acid in the sample,
and produces low yields of RoV-specific sequence (in
comparison to other species) upon next generation se-
quencing. Despite the introduction of a whole genome
nomenclature for RoV, whole genome sequencing is yet
to be universally adopted for routine identification, sur-
veillance and phylogenetic studies. This is because the
whole genome sequencing of RoV is far from straightfor-
ward and relies on the independent amplification of each
segment from a positive fecal sample. The combination
of dsRNA, fecal extraction as an amplification template,
untypeable viruses and highly polymorphic sequences
add to this complexity. The presence of mixed infection
of a single sample with multiple RoV, reported in ap-
proximately 10% of infections in developed countries
[16, 17] and 21–48% in low income countries [18, 19],
further complicates RoV genotyping and sequencing
efforts. The use of Sanger sequencing methods, which
generate a single consensus sequence based on nucleo-
tide abundance, does not permit the detection of genetic
variation or the presence of multiple viruses within a
sample, both of which may bias inference related to RoV
infection and evolution. Random amplification com-
bined with next generation sequencing (NGS) methods
can be utilized overcome many of the complications that
prevent the generation of adequately characterised RoV
gene sequences representative of the complete diversity
present in a single sample. However, there are still
barriers; feces is a complex starting material, containing
inhibitors and a wide diversity of organic material, and it
is likely that RoV dsRNA will be of low yield in compari-
son to nucleic acid from other more copious viruses,
prokaryotes, and eukaryotic cells found in the gastro-
intestinal tract. To overcome these issues, we present
here a novel method suitable for the generation of whole
genome sequences of RoV directly from human fecal
specimens.
Results
A novel method for the purification of rotavirus nucleic
acid from fecal samples
To address the limitations surrounding RoV nucleic acid
purification, we developed a new method utilizing com-
mercial enzyme immunoassay (EIA) plates to capture RoV
particles suitable for RNA extraction and amplification.
This procedure is described in detail in the Methods; Fig. 1
shows a flow diagram outlining the various laboratory
steps. Briefly, fecal samples testing positive for RoV by
Reverse Transcriptase (RT)-PCR were captured using EIA
plates, exogenous nucleic acids removed, and RNA ex-
tracted from the captured viral particles. In order to
prepare the purified RoV RNA for genome sequencing the
RNA was converted to double-stranded cDNA prior
to standard library preparation necessary for Illumina
sequencing.
Rotavirus purification for genome sequencing is
dependent on viral load
We first performed and validated the RoV purification
method on a human fecal sample that contained a high
yield (Ct value = 15, estimated 1 × 108 copies) of the
most common RoV genotype in human infections,
G1P[8] (Table 1). We found that purification of viral
particles on EIA plates and the conversion to cDNA
substantially reduced the yield of RoV RNA, producing
sequential Ct values of 23 and 28.5 at each step, respect-
ively (Table 1). However, after random amplification
[20], the Ct value was restored to 15 and subsequent
genome sequencing on an Illumina MiSeq machine
produced >600,000 reads, of which >50% could be
attributed to RoV (i.e. <50% contamination with non-
RoV sequences) with >90% genome coverage (Table 1).
Predictably, after performing several serial dilutions, we
found the RoV purification method was highly sensitive
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to viral load, with minimal RoV sequences produced at a
starting Ct value of 25 and no RoV sequences produced
when the initial starting Ct value was >30 (estimated
<1 × 103 copies) (Table 1).
Validation of method for the genome sequencing of
differing rotavirus genotypes
We next aimed to assess the performance of the RoV
purification and sequencing method on a range (n = 26) of
samples containing common (G1P[8]) and less common
RoV genotypes, these included more “exotic” genotypes
such as G26P[19] and previously untypeable RoV positive
samples (samples for which a G/P type could not be deter-
mined using the conventional PCR amplification method).
Only samples with a primary Ct value for RoV of <25 were
chosen. Random amplification and Illumina sequencing of
all 26 samples, including those containing untypable RoV,
yielded large amounts of sequences associated with RoV.
The number of RoV reads ranged from ~66,000 to
>1,500,000 (median = 761,135) and the percentage of
reads corresponding with RoV in the final sequencing data
ranged from 7.4% to >97% (Table 2).
Fig. 1 The procedure for rotavirus capture and nucleic acid preparation prior to genome sequencing. Flow diagram describing the major
protocol steps required for the purification of RoV and the amplification of RoV specific nucleic acid for next generation genome sequencing.
Image of Illumina MiSeq obtained from https://assets.illumina.com/content/dam/illumina-marketing/images/systems/miseqdx/web-graphic-miseq-
front-comparison-chart.jpg. Clipart image of pipette obtained from http://www.clker.com/clipart-pipette-with-tip.html. Clipart image of 96-well
plate obtained from http://cyberuse.com/96-well-plate-template.html. Clipart image of Eppendorf tube obtained from http://www.clker.com/
clipart-eppendorf-tube-with-open-cap-1.html and edited in Adobe Illustrator
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Optimisation of rotavirus cDNA amplification for genome
sequencing
We measured the ability of the method to produce se-
quences that covered all 11 segments of the RoV gen-
ome. We found that, even when the proportion of reads
associated with RoV was low for some samples, that the
genome coverage (per base) was high, with 20/26 of the
RoV positive samples producing sequences correspond-
ing with >90% coverage of reference genomes (median
coverage, 92.5%; interquartile range (IQR), 90.7–94.7%).
However, we additionally found that the resulting se-
quences were highly influenced by segment length. The
Table 1 Concentration of rotavirus required for genome sequence generation
Sample Initial input Post-viral capture Double-stranded
cDNA
Random
amplification
Genome sequencing
Ct value Target
copies
Ct value Target
copies
Ct value Target
copies
Ct value Target
copies
Total reads Number of
RoV reads
Proportion of
RoV reads (%)
RoV genome
coverage (%)
Neat 15 1 × 108 23 6 × 105 28.53 1 × 104 14.97 1 × 108 6 × 105 3 × 105 54.5 90.4
Dilution (2−5) 20 4 × 106 28 2 × 104 34.9 2 × 102 19.59 6 × 106 7 × 105 2 × 105 20.7 81.3
Dilution (2−10) 25 1 × 105 33 6 × 102 37.44 3 × 101 23.9 3 × 105 8 × 105 5 × 103 0.7 49.3
Dilution (2−15) 30 7 × 103 36 8 × 101 Negative 0 Negative 0 8 × 105 6 × 102 0.07 26.7
Dilution (2−16) 32 1 × 103 Negative 0 Negative 0 Negative 0 0 0 0 0
Table 2 Concentration of rotavirus in samples at each step of the capture and amplification process
Sample
ID
GP type Initial input Post-viral capture Double-stranded cDNA Random amplification Genome sequencing
Ct value Target copies Ct value Target copies Ct value Target copies Ct value Target copies Total reads RoV reads
(% output)
VN-0002 G1P[8] 13.25 4 × 108 22.75 7 × 105 28.25 2 × 104 16.3 5 × 107 1,009,250 951,969 (94.3)
VN-0006 G1P[8] 15.28 1 × 108 24.78 2 × 105 30.28 4 × 103 18.02 2 × 107 1,102,774 932,674 (84.6)
VN-0013 G1P[8] 14.07 2 × 108 23.57 4 × 105 29.07 9 × 103 23.18 5 × 105 1,172,366 1,087,933 (93.0)
VN-0057 G1P[8] 10.31 3 × 109 19.81 5 × 106 25.31 1 × 105 16.92 4 × 107 1,269,282 910,567 (71.7)
VN-0030 G1P[8] 11.66 1 × 109 21.16 2 × 106 26.66 5 × 104 18.45 1 × 107 1,064,026 78,217 (7.4)
VN-0062 G1P[8] 8.3 1 × 1010 20.45 3 × 105 35.65 1 × 102 20.55 3 × 106 1,037,480 778,628 (75.1)
VN-0324 G1P[8] 17.54 2 × 107 27.04 4 × 104 32.54 9 × 102 20.12 4 × 106 1,279,046 1,042,325 (81.5)
VN-0365 G1P[8] 13.82 3 × 108 23.32 5 × 105 28.82 1 × 104 15.89 7 × 107 1,305,760 1,271,769 (97.4)
VN-0299 G1P[8] 14.22 2 × 108 23.72 4 × 105 29.22 8 × 103 27.8 2 × 104 1,266,286 1,149,123 (90.8)
VN-0172 G1P[8] 14.3 1 × 1010 23.80 3 × 105 29.3 8 × 103 19.63 6 × 106 1,816,574 1,298,619 (71.5)
VN-0341 G1P[8] 12.14 9 × 108 21.64 1 × 106 27.14 3 × 104 20.61 3 × 106 1,668,438 1,514,101 (90.8)
VN-0221 UT 18.38 1 × 107 27.88 2 × 104 33.38 5 × 102 30.63 3 × 103 1,479,948 336,552 (22.7)
VN-0186 UT 17.7 2 × 107 27.20 3 × 104 32.7 8 × 102 24.78 2 × 105 1,459,470 1,440,853 (98.7)
VN-0175 UT 24.25 2 × 105 33.75 4 × 102 39.25 9 × 101 29.96 5 × 103 1,306,208 1,138,961 (87.2)
VN-0181 UT 25 1 × 105 34.50 2 × 102 40 5 × 101 30.44 4 × 103 1,285,912 140,328 (10.9)
VN-0222 G2P[4] 18.76 1 × 107 28.26 2 × 104 33.76 4 × 102 23 6 × 105 1,289,724 1,204,896 (93.4)
VN-0321 G2P[4] 21.62 1 × 106 31.12 2 × 103 36.62 5 × 101 26 7 × 104 1,113,180 724,701 (65.1)
VN-0326 G2P[4] 13.5 4 × 108 23.00 6 × 105 28.5 1 × 104 27.48 3 × 104 426,240 347,019 (81.4)
VN-0058 G26P[19] 17 1 × 1010 26.50 5 × 104 32 1 × 103 28.98 1 × 104 1,434,422 739,222 (51.5)
VN-0132 G3P[4] 16.66 4 × 107 26.16 7 × 104 31.66 2 × 103 23.68 4 × 105 1,316,574 743,642 (56.5)
VN-1221 G2P[4] 13.25 4 × 108 22.75 7 × 105 28.25 1 × 103 16.26 1 × 104 700,632 555,195 (79.2)
VN-0074 G1P[8] 14.8 2 × 108 24.30 2 × 105 29.8 6 × 103 16.87 4 × 107 991,014 153,654 (15.5)
VN-0140 G1P[8] 13.21 4 × 108 22.71 7 × 105 28.21 1 × 103 15.7 1 × 104 665,478 578,601 (87.0)
VN-0196 G9P[4] 16.18 6 × 107 25.68 9 × 104 31.18 2 × 103 17.28 3 × 107 743,184 66,378 (8.9)
VN-3096 G1P[4] 13.52 4 × 108 23.02 6 × 105 28.52 1 × 103 15.78 1 × 104 567,266 381,270 (67.2)
VN-1604 G2P[4] 15.31 1 × 108 24.81 2 × 105 30.31 4 × 103 17.55 2 × 107 670,404 330,173 (49.3)
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VP1 (3,302 bp) and VP2 (2,690 bp) regions exhibited a
median coverage of >99.9%, whilst the smaller segments,
such as NSP4 (751 bp) and NSP5 (667 bp), exhibited a
median coverage of only 77.4% (IQR, 61.5–92.3%) and
52.6% (IQR, 27.8–86.4%), respectively (Table 3). These
data suggest a limitation of the random amplification pro-
cedure due to an amplification bias against the shorter
RoV genome segments. The underrepresentation of the
NSP genes (NSP2-5) and VP7 in the final genome se-
quences for three selected samples (VN-0006 (G1P[8]),
VN-0058 (G26P[19]) and VN-0132 G3P[4])) can be
observed in the sequence coverage plots in Fig. 2.
To enhance our ability to amplify entire RoV genomes
from fecal samples, improve the coverage of the shorter
genome segments and reduce contaminating sequences
from other species, we aimed to enrich the amplification
process prior to genome sequencing. We used a combin-
ation of the random primer FR26RVN and new FR26RV
specific primers, exploiting conserved terminal sequences
for each segment to generate specific primers for each of
11 segments (Table 4). We selected seven samples (VN-
0172, VN-0341, VN-0221, VN-0181, VN-0058, VN-0132
and VN-0006) that generated incomplete sequences for
the shorter genome segments using the random amplifica-
tion primers alone and repeated the amplification step
with the new primer combinations. The addition of the
primer cocktail substantially improved the production of
complete genome sequences. Specifically, we were able to
generate enhanced coverage of all of the short segments,
with the median coverage of NSP2, NSP4 and NSP5 in-
creasing from 70 to 99.9%, from 57.5 to 86.8% and 45 to
86%, respectively (Tables 3 and 5). The coverage plots in
Fig. 2 show the effect of the modified primer cocktail on
whole genome amplification and segment sequencing for
three selected samples: VN-0006, VN-0058 and VN-0132.
Novel insights into rotavirus infections and phylogenetics
Once the purification and amplification for RoV was
optimised, we performed analysis on the sequences of
the 26 RoV positive samples that had been generated
through the modified sequencing protocol. All samples
had high coverage, suitable for further downstream se-
quence and phylogenetic analyses. Firstly, we used the
conventional loci (VP4 and VP7) to genotype the 26
samples into G and P types. We were able to determine
the genotype in all 26 samples, with 22/26 correspond-
ing with the original predicted genotype that was deter-
mined using conventional genotyping methods and 4/26
samples providing discrepant results. We found that
these four samples were identified to have untypeable
RoV by initial genotyping (VN-0221, VN-0186, VN-0175
and VN-0181), while genome sequencing revealed that
these infections were induced by RoV genotypes G2P[4],
G2P[4], G2P[4] and G1P[4], respectively.
We further found that 5/26 samples produced genome
sequences that included multiple sequences of differing
genotypes for one or more individual segments. Hypothe-
sizing co-infection, we examined the varying segments
and the potential genome constellations of the sequences
generated via the capture-amplification method (VN-
0326, VN-0132, VN-1221, VN-0196 and VN-0074). Given
the segment coverage and the most likely segment combi-
nations to form genome constellations (Fig. 2), these sam-
ples were found to be probable co-infections of G1P[8]/
G2P[4], G3P[8]/G2P[4], G2P[4]/G3P[8], G9P[8]/G8P[4]
and G1P[8]/G8P[4]. In all examples, we could detect a
major and minor RoV genotype in the sequences (major
variant appearing first in the above description (Fig. 3)),
with segment coverage roughly associating with read
depth. Notably, in all of these co-infection samples, we
did not generate sequences for all segments, particu-
larly the shorter segments which were again underrep-
resented. NSP4 was missing in the minor RoV genotype
in all samples and all non-structural protein segments
were missing in the minor variant in sample VN-0074.
Finally, to examine potentially reassortant G1P[8] se-
quences (VN-0140, VN-0299, VN-0341, VN-0365), we per-
formed segment-specific phylogenetic analyses of G1P[8]
and G2P[4] sequences with standard Wa-like or DS-1-like
backbone constellations [21], including 16 samples se-
quenced herein. Maximum likelihood phylogenies dem-
onstrated strong support for two different lineages
(Wa-like versus DS-1-like) for each of the segments
(Additional file 1: Figure S1). This divergence is
highlighted in the VP7 phylogeny (Fig. 4), where the G1
and G2 genotypes form two distinct, well-supported clades.
The corresponding visualization of genome constellations
shows an association between the G2 genotype and the DS-
1-like backbone as well as the G1 genotype and the Wa-like
backbone for all but four of the Vietnamese sequences.
These sequences (VN-0140, VN-0299, VN-0341, VN-0365)
instead show G1P[8] associated with a DS-1-like backbone.
Comparison of the phylogeny of VP7 to those of VP4 and
VP6 captures the phylogenetic incongruity between
segment-specific phylogenies (Fig. 5). Mixing of reassortant
virus segments can be additionally observed in the VP7-
VP6 tanglegram, while the VP7-VP4 tanglegram shows VP7
and VP4 sequences to be associated by genotype, suggesting
a common phylogenetic history. A comparison between
VP7 and all other segments is shown in Additional file 1:
Figure S1. While reassortment among RoV segments is not
uncommon, standard RoV genotyping only captures reas-
sortment between the VP7 and VP4 segments, and suggests
that these infections resulted from typical G1P[8] RoV.
Discussion
Realising the need for a reliable approach for producing
RoV genome sequences without the requirement for
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viral culture, we have developed a methodology that
reproducibly generates RoV genome sequences directly
from infected human fecal specimens, producing nearly
complete genomes (>90% genome coverage) for 100% of
the 26 samples tested. This represents a significant
improvement over previous full genome sequencing
approaches utilized for large-scale evolutionary analysis,
which yielded nearly complete genomes in less than 45%
of sequencing attempts [17, 22, 23]. Our novel approach
bypasses many of the current restrictions for generating
virus-specific genome sequences directly from fecal
material. Further, our method reduces contamination
with non-RoV sequences that may overwhelm the final
sequence output, which can occur using non-selective
nucleic acid purification and amplification procedures
prior to sequencing. By using diagnostic ProspecT RoV
EIA plates, with an adapted methodology, we show that
RoV can be reliably purified in appropriate concentra-
tions for downstream amplification and genomic ana-
lyses. These EIA plates are commercially available, and
the World Health Organization (WHO) RoV Surveil-
lance Network has included these kits in the WHO-
GSM (Global Management System) catalogue for easy
procurement for participating RoV surveillance network
laboratories. Therefore, our technique could theoretically
be rolled out throughout participating RoV Surveillance
Network laboratories following routine diagnosis. We add-
itionally suggest that the presented method is more simplis-
tic than other genome sequencing approaches and could be
performed for RoV or other viral diarrheal pathogens (kits
are available for norovirus, astrovirus and other enteric
pathogens), in a basic molecular virology/microbiology
Fig. 2 Rotavirus nucleic acid enrichment for whole genome sequencing. Circular plots showing the coverage (i.e. the amount of sequence
produced across each segment) of each of the 11 RoV segments (highlighted) and the coverage depth of each of the segments after Illumina
sequencing for three RoV-positive samples (top, middle, bottom). Plots show coverage and depth following viral capture and random amplification
(left, before) and following viral capture and amplification with both random and specific primers (right, after)
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laboratory with access to a thermal cycling machine.
Furthermore, given the high affinity for RoV particles on
the EIA plates and the likely stability post-purification, we
predict that RoV capture prior to extraction and amplifica-
tion could be performed at field sites and shipped to a
central local or international reference laboratory for direct
amplification and genome sequencing.
Current RoV surveillance is largely performed using
G/P typing alone, which is dependent on PCR amplifica-
tion and sequencing of the genes encoding the VP4 and
VP7 surface antigens, respectively. G/P typing conven-
tionally utilises Sanger sequencing and is unable to de-
termine a G/P type for all RoV positive fecal specimens.
Indeed, in 2013, the WHO RoV Surveillance Network
reported 0.6% to 9.1% prevalence of untypable RoV
strains in fecal specimens depending on the location
[24]. Our findings suggest that untypable RoV strains
may be an artefact of methodology created via an inabil-
ity to generate reliable PCR amplicons for the VP4 and
VP7 genes from fecal extractions. Here we found that 4/
24 previously untypable RoV strains were actually con-
ventional G2P[4] and G1P[4] strains for which we could
not produce a PCR amplicon suitable for conventional
sequencing. We predict that the purification and gen-
ome sequencing of additional untypable samples would
generate new insights into the global epidemiology and
strain diversity of RoV. Our ability to generate genome
sequences from a wide range of genotypes suggests that
this methodology has a good utility and, given the global
introduction of RoV vaccination, would assist in the de-
velopment of a robust and expandable system of mo-
lecular epidemiology through routine RoV surveillance.
Given the global relevance of RoV and likely impact of
RoV immunization in coming years, there is a paucity of
genomic data for this ubiquitous RNA virus in compari-
son to other RNA viruses that have a dramatic impact
on global health. Much of our inference of RoV strain
circulation, epidemiology and evolution has been derived
from current inadequate typing methods. Our data,
whilst generated from a small sample size, predicts that
coinfection and reassortment are common and likely go
undetected at a large scale. We could identify and confirm
(by specific sequences) four differing RoV combinations
contributing to mixed infections (G1P[8]/G2P[4], G3P[8]/
G2P[4], G9P[8]/G8P[4] and G1P[8]/G8P[4]). We add-
itionally identified four reassortant viruses (G1P[8] with a
DS-1-like backbone) in this restricted cross-section of
RoV sequences. There are limited data regarding both
mixed infection and reassortment, although both of these
biological processes are thought to play an important role
in the generation of new variants and may affect patho-
genesis and disease phenotype. Current models of RoV
evolution predict that while VP7 and VP4 segments
reassort frequently, reassortment is less common amongst
the segments comprising the genomic backbone, which
likely maintain preferred genome constellations deter-
mined by protein-protein interactions across different seg-
ments [17, 22]. However, the frequency and genomic
dynamics of mixed infection, a prerequisite for reassort-
ment, are poorly understood due to a lack of adequate
methods to characterize multiple co-infecting viral seg-
ments in a single sample. The method described here
could be utilized to fill this knowledge gap by providing
full RoV genomic data at an epidemiological scale, which
would allow for a more accurate characterization of circu-
lating RoV, investigation of mixed infection and reassort-
ment dynamics, and analysis of RoV genomic diversity
and dynamics pre- and post-vaccine introduction.
There are some limitations to our methodology that
may necessitate some optimization prior to the universal
acceptance of this sequencing strategy. First, the gener-
ation of double-stranded cDNA, whilst reliable, is rela-
tively laborious and could be streamlined by using
commercially available kits to provide greater utility in
Table 4 Primers used for rotavirus genome enrichment
amplification
Primer name Primer sequences (5'-3')
FR20RV
Modified FR26RVN
FR26RV-VP7-F
FR26RV-VP7-R
GCCGGAGCTCTGCAGATATC
GCCGGAGCTCTGCAGATAT-non ribosomal
hexanucleotides [2]
GCCGGAGCTCTGCAGATATCGGCTTTAAAAG
GCCGGAGCTCTGCAGATATCGGTCACATCATA
FR26RV-VP4-F
FR26RV-VP4-R
FR26RV-VP4-F2
FR26RV-VP4-R2
GCCGGAGCTCTGCAGATATCGGCTATAAAATG
GCCGGAGCTCTGCAGATATCGGTCACATCCTC
GCCGGAGCTCTGCAGATATCTGGCTTCGCCAT
GCCGGAGCTCTGCAGATATCATTTCGGACCAT
FR26RV-VP6-F
FR26RV-VP6-R
GCCGGAGCTCTGCAGATATCGGCTTTWAA ACG
GCCGGAGCTCTGCAGATATCGGTCAC ATCCTC
FR26RV-VP1-Fb
FR26RV-VP1-Rb
GCCGGAGCTCTGCAGATATCGGCTATTAAAGC
GCCGGAGCTCTGCAGATATCGGTCACATCT
FR26RV-VP2-Fc
FR26RV-VP2-Rc
GCCGGAGCTCTGCAGATATCGGCTATTAAAGG
GCCGGAGCTCTGCAGATATCGTCATATCTCCA
FR26RV-VP3-Fe
FR26RV-VP3-Re
GCCGGAGCTCTGCAGATATCGGCTWTTAAAGC
GCCGGAGCTCTGCAGATATCGGTCACATCATG
FR26RV-NSP1-F
FR26RV-NSP1-R
GCCGGAGCTCTGCAGATATCGGCTTTTTTTTATG
GCCGGAGCTCTGCAGATATCGGTCACATTTTATGC
FR26RV-NSP2-F
FR26RV-NSP2-R
GCCGGAGCTCTGCAGATATCGGCTTTTAAAGC
GCCGGAGCTCTGCAGATATCGGTCACATAAGC
FR26RV-NSP3-F
FR26RV-NSP3-R
FR26RV-NSP3-R2
GCCGGAGCTCTGCAGATATCGGCTTTTAATGC
GCCGGAGCTCTGCAGATATCACATAACGCCCCTAT
GCCGGAGCTCTGCAGATATCGGTCACATAACG
FR26RV-NSP4-F1
FR26RV-NSP4-F2
FR26RV-NSP4-R1
FR26RV-NSP4-R2
GCCGGAGCTCTGCAGATATCGGCTTTTAAAAGTTC
GCCGGAGCTCTGCAGATATCGCDTCAATTCCAAC
GCCGGAGCTCTGCAGATATCTAAGACCRTTCC
GCCGGAGCTCTGCAGATATCCTCCGCCGCTTCCGA
FR26RV-NSP5-F1
FR26RV-NSP5-F2
FR26RV-NSP5-R1
FR26RV-NSP5-R2
GCCGGAGCTCTGCAGATATCGGCTTTTAAAGCGCT
GCCGGAGCTCTGCAGATATCGGCTTTTAAAGCGCT
GCCGGAGCTCTGCAGATATCCTATCTGAATCATC
GCCGGAGCTCTGCAGATATCGGTCACAAAACGGGA
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field locations. Second, the methodology proved to be
reliable only on samples with a Ct value of <30, which
may limit the study of prolonged infections and fecal
carriage, which have been described to have a lower viral
load than acute infections [25, 26]. Third, we validated the
method on a cohort of young children with symptomatic
Fig. 3 Rotavirus coinfection is characterized by a major and a minor population. Dark grey bars and blue lines indicate the percentage sequence
coverage and total number of reads (log scale), respectively, for each of the 11 RoV segments for the majority population present in five samples
containing coinfecting RoV populations. Light grey bars and red lines indicate the percentage sequence coverage and total number of reads (log
scale), respectively, for each of the 11 rotavirus A segments for the minority rotavirus population present in five samples containing coinfecting
rotavirus populations
Dung et al. BMC Genomics  (2017) 18:324 Page 10 of 16
infections in Vietnam and the method may need further
testing on archived and non-archived samples from differ-
ing locations where RoV strain circulation may be more
variable. Lastly, the use of Illumina sequencing makes the
outlined method more costly than current genotyping
methods. However, given the wealth of data generated and
the decreasing costs of next generation sequencing, we
present the proposed method as a first step toward a re-
producible system for investigating global RoV molecular
epidemiology and surveillance of RoV population struc-
tures pre- and post-vaccine introduction.
Conclusions
We have developed and evaluated a genome sequencing
method for RoV from human fecal specimens using
commercial available EIA plates and a comparatively
simple assortment of molecular biology reagents. The
methodology is reliable but requires further validation in
a broader context and may provide new biological and
epidemiological insights into RoV strain diversity and
disease phenotype.
Methods
Clinical specimens and detection of rotavirus
The fecal specimens used in this study were collected
from children recruited into a randomized controlled
trial for probiotics treatment conducted at Children’s
Hospital Two in Ho Chi Minh City (HCMC), Vietnam.
A full description of the methods has been published
elsewhere [27]. Hospitalised patients between 9 and
60 months of age with acute, non-bloody, non-
mucoid, watery diarrhoea and a history of less than
three days were eligible to enter the trial. Patients
could not enter the trial if they had at least one
episode of diarrhoeal disease in the month prior to
admission, they were known to have short bowel
syndrome or chronic (inflammatory) gastrointestinal
disease, they were immunocompromised or immuno-
suppressed, they were on prolonged steroid therapy
or if they were diagnosed as severely dehydrated.
Diarrhea was defined as three watery or loose stools
within 24 h or one episode of bloody and/or mucoid
diarrhoea [28].
Fig. 4 Genome constellations suggest intergenotype reassortment in Vietnamese G1P[8] and G2P[4] rotaviruses. A maximum likelihood
phylogeny of VP7 gene sequences is shown with genome constellations mapped at the tips of the tree. Standard Wa-like genome segments are
indicated by light grey blocks, DS-1-like segments by dark grey blocks. Taxa names in bold indicate Vietnamese sequences from this study; taxa
names in red indicate likely reassortant Vietnamese sequences. Asterisks indicate ≥85% bootstrap support at internal nodes of interest
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After collection, fresh fecal samples were stored on
site and transported to Oxford University Clinical Re-
search Unit in HCMC. All fecal samples were subject to
molecular testing to detect RoV and norovirus as previ-
ously described [29]. Briefly, total RNA was extracted
from fecal samples, reverse transcribed into cDNA and
used as template for real-time PCR. Fecal samples were
stored at −80 °C. For real-time quantitative PCR, ampli-
fications were performed using RNA Master hydrolysis
probes (Roche Applied Sciences, West Sussex, United
Kingdom) and optimized with 1.4 μl of activator on a
LightCycler 480II (Roche Applied Sciences, Mannheim,
Germany). Five μl of RNA was mixed with 20 μM for
each primer and 10 μM probe, and thermal cycling was
a
b
Fig. 5 Phylogenetic incongruity among rotavirus segments confirming genomic reassortment. Diagram outlines G1P[8] VP7-VP4 segments and the
DS-1-like backbone segments in four Vietnamese G1P[8] rotaviruses. a Tanglegram showing corresponding VP7 and VP4 segments of G1P[8] and
G2P[4] genotypes. b Tanglegram showing phylogenetic incongruity between the VP7 and VP6 segments of the G1P[8] and G2P[4] genotype for four
reassortant rotaviruses from Vietnam. Sequences from nonreassortant Vietnamese rotaviruses are indicated by connection with black lines. Sequences
from reassortant Vietnamese viruses are indicated by connection with red lines. Segments between which no reassortment is detected (i.e. VP7-VP4)
are depicted with reassortant viruses connected by red dashed lines. Asterisks indicate ≥85% bootstrap support at internal nodes of interest
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initiated at 61 °C for 5 min for reverse transcription,
5 min at 95 °C for amplification, and then by 45 cycles
at 95 °C for 5 s and 60 °C for 45 s. Copy number of the
target sequence was inferred using a standard curve gen-
erated as previously described [29].
Preparation of rotavirus nucleic acid for genome
sequencing
The procedure for this RoV extraction is shown in Fig. 1.
RoV-positive fecal samples were diluted 1:1 with sterile
DNase treated phosphate-buffered saline prior to mix-
ing. Four hundred μl of fecal suspension was subjected
to centrifugation at 10,621 × g in a benchtop microfuge
for 10 min to sediment cellular debris, bacteria and
mitochondria. The supernatants (containing viral parti-
cles) were removed by sterile Pasteur pipette and 20U of
TURBO DNase (Ambion, Warrington, UK) was added
to 200 μl of the resulting solution prior to incubation at
37 °C for 1 h to eliminate exogenous DNA. The DNase-
treated supernatant was inoculated into the wells of
ProspecT RoV EIA plates (Oxoid, Basingstoke, UK)
using twice the volume recommended by the manufac-
turer along with the RoV-specific polyclonal antibody
conjugated to horseradish peroxidase. RoV antigen in the
sample was captured between the solid phase antibody on
the plate surface and the enzyme-conjugated antibody.
After one-hour incubation at ambient temperature, the
wells on the EIA plates samples were washed nine times
with washing buffer contained in the kit and three times
with phosphate buffered saline.
After washing to remove unattached viral particles and
other contaminants 750 μl of TRIzol LS (Life Technolo-
gies, Paisley, UK) was added into each of the wells on the
EIA plate. The resulting lysate was removed from the EIA
plates and used as the input material for a conventional
TRIzol extraction following the manufacturer’s instruc-
tions. The resulting pellet of nucleic acid was resuspended
in 20 μl of nuclease-free water (Ambion, Warrington, UK)
prior to the removal of residual DNA with a secondary
addition of TURBO DNase (Ambion, Warrington, UK)
after incubation at 37 °C for 1 h. Reverse transcription
with Superscript III (Invitrogen) was performed as previ-
ously described [20], using the modified primer FR26RVN
(a 20-bp primer sequence with nonribosomal random
hexamers at the 3′ end) at a concentration of 1 μM
(Table 4) [30]. We further aimed to improve the coverage
of the short RoV genome segments and reduce contamin-
ating sequences using a combination of the random pri-
mer FR26RVN (1 μM) and FR26R-specific primers (20
nM). We additionally exploited two conserved terminal
sequences for each segment [31] to generate specific
primers for each of the 11 segments (Table 4).
For PCR amplification prior to sequencing, 8 μL of ex-
tracted RNA was mixed with 1 μl of a solution containing
dNTPs at 10 mM, 3 μl of modified FR26RVN primer and
1 μL of mixture of FR26RV-specific primers (Table 4). The
solution was incubated at 65 °C for 5 min and then placed
on ice. A reaction mix of 7 μl containing 4 μl of 5x buffer
(Invitrogen, Paisley, UK), 1 μl of 0.1 M DTT (Invitrogen,
Paisley, UK), 1 μl of recombinant RNase inhibitor (Invitro-
gen, Paisley, UK) and 1 μl of reverse transcriptase
Superscript III (Invitrogen, Paisley, UK) was added. The
reaction was incubated at 25 °C for 10 min, 37 °C for
50 min and 75 °C for 15 min. Subsequently, second strand
DNA synthesis was performed with 5 U of Klenow frag-
ment 3′-5′ exo – (New England Biolabs, Hitchin, UK) at
37 °C for 60 min. A final incubation at 75 °C for 10 min
was performed to terminate the Klenow reaction. Finally,
random PCR was used to produce a sufficient yield of
DNA from the ds cDNA template for Illumina se-
quencing. A 50 μl PCR reaction mix consisted of
45 μl Platinum PCR Supermix High Fidelity (Invitro-
gen, Paisley, UK), 1 μM of the primer FR20RV
(GCCGGAGCTCTGCAGATATC) and 4 μl of the ds
cDNA template. After 2 min at 94 °C, the reaction
underwent 40 cycles of amplification (94 °C for 30 s,
60 °C for 1 min, and 72 °C for 2 min).
Genome sequencing
The Nextera XT DNA Library Preparation kit (Illumina,
Cambridge, UK) was used to generate the sequencing li-
brary. After purification using the Agencourt AMPure XP
PCR kit (Beckman Coulter, Krefeld, Germany), the puri-
fied DNA library was quantified using Qubit dsDNA HS
Assay kit (Life Technologies, Paisley, UK), a fluorometric-
based method specific for duplex DNA quantification; the
sample was then diluted to 0.2 ng/μl. Five μl of input
DNA (1 ng total) was tagmented (tagged and fragmented)
by the Nextera XT transposome to add unique adapter
sequences. Subsequently, a limited-cycle PCR reaction
targeted these adapters to amplify insert DNA and add
index sequences on both ends of the DNA, thus enabling
dual-indexed sequencing of pooled libraries. Samples were
pooled and Kappa PCR (Kapa Biosystems, West Sussex,
UK) was performed before pooling to determine the quan-
tity of each library in the pooled sample. Sequencing was
performed with 24 samples multiplexed per run on a
MiSeq platform (Illumina) for 300 cycles (150-bp paired-
end reads).
Sequence analysis
Before analysing the generated RoV sequences, some
simple quality control measures were always performed to
ensure that raw data were of sufficient quality and there
were no complications or biases in the raw sequence data.
FastQC software [32] (http://www.bioinformatics.babraha-
m.ac.uk/projects/fastqc/) was used to assess overall sequence
quality. Raw Illumina paired-end reads were trimmed of
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adapter sequences and quality filtered using Trim Galore
(http://www.bioinformatics.babraham.ac.uk/projects/trim_ga
lore/). To identify the nearest RoV reference strain for each
sample, the BLAST toolkit was used to search for the best
match in the NCBI nucleotide database for every read using
the MEGABLAST option [33]. The filtered sequence data
were then mapped against a database of RoV reference genes
using SMALT (http://www.sanger.ac.uk/science/tools/smalt-
0). RoV reference files contained segment-specific sequences
representing all of the known RoV diversity downloaded
from GenBank using BLAST searches of the reference
sequences of all known RoV genotypes. Segment-specific
consensus sequences were constructed from read mapping
(BAM) based on simple majority rules using script bam2con-
s.py written in Python from ViPR software (https://github.-
com/CSB5/vipr). The bam2cons_iter.sh uses BWA to do
iterative mapping of the reads to the reference sequence until
a consensus is generated based on the maximum frequency
of nucleotide at a given position [34]. This process was con-
ducted individually for each of the eleven RoV segments.
LoFreq2 was then used to detect the single nucleotide vari-
ants present in the sample [35]. Visualization of the genome
coverage graph for the segments of interest and SNPs identi-
fied by LoFreq2 were plotted using Circos software [36]. In
cases of multi-genotype mixed infections, a major and minor
population was called based on the number of reads for each
segment and the expected genotypes given the G-P (VP7/
VP4) types present in the sample, with the genome constella-
tion with the highest number of reads referred to as the
major population and that with the lowest number of reads
referred to as the minor population.
Phylogenetic analysis
Among the sequences determined here, we observed four
genome sequences representing potential reassortants
(samples VN-0140, VN-0299, VN-0341, VN-0365), posses-
sing G1P8 capsid genes (VP7 and VP4) with a DS-1-like
backbone (I2-R2-C2-M2-A2-N2-T2-E2-H2) (Fig. 3). To
further investigate these sequences, segment-specific
databases were compiled for the potential reassortants,
Vietnamese G1P8 and G2P4 sequences with a standard
Wa-like or DS-1-like genome constellation, and a repre-
sentative subsample of G1P8 RoV with a Wa-like back-
bone (I1-R1-C1-M1-A1-N1-T1-E1-H1) and G2P4 RoV
with a DS-1-like backbone were obtained from the Virus
Pathogen Resource (ViPR) database (http://www.viprbr-
c.org/), and manually aligned using Geneious (v9.0).
Segment-specific maximum likelihood (ML) trees were
then inferred using RAxML [37] under the GTRGAMMA
model with 500 bootstrap replications; this model was
chosen for computational simplicity, as the best-fit
nucleotide substitution model for each dataset could be
approximated by or was nested in the GTRGAMMA
model, as determined using jModelTest [38]. These trees
were then utilized to generate tanglegrams for visualizing
the relationships between reassortant segments using
Dendroscope 3 [39].
Additional file
Additional file 1: Figure S1. Phylogenetic incongruity confirms
reassortment of G1P[8] VP7-VP4 segments and DS-1-like backbone segments in
four Vietnamese G1P[8] rotaviruses. (A) Tanglegram showing correspondence
across VP7 and VP4 segments of the G1P[8] and G2P[4] genotype. (B)
Tanglegram showing phylogenetic incongruity for the VP7 and VP6 segments of
the G1P[8] and G2P[4] genotype for four reassortant rotaviruses from Vietnam.
(C) Phylogenetic incongruity in VP7 and VP1. (D) Phylogenetic incongruity in VP7
and VP2. (E) Phylogenetic incongruity in VP7 and VP3. (F) Phylogenetic
incongruity in VP7 and NSP1. (G) Phylogenetic incongruity in VP7 and NSP2. (H)
Phylogenetic incongruity in VP7 and NSP3. (I) Phylogenetic incongruity in VP7
and NSP4. (J) Phylogenetic incongruity in VP7 and NSP5. In all tanglegrams,
sequences from nonreassortant Vietnamese rotaviruses are indicated by
connection with black lines. Sequences from reassortant Vietnamese viruses are
indicated by connection with red lines. Segments between which no
reassortment is detected (i.e. VP7-VP4) are depicted with reassortant
viruses connected by red dashed lines. Asterisks indicate ≥85%
bootstrap support at internal nodes of interest. (PDF 3252 kb)
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